Young women with locally advanced breast cancer who achieve breast conservation after neoadjuvant chemotherapy have a low local recurrence rate

American Surgeon

Volumn 77, Issue 7, 2011, Pages 850-855

  Sweeting, Raeshell S ^a   Klauber DeMore, Nancy ^a   Meyers, Michael O ^a   Deal, Allison M ^a   Burrows, Emily M ^a   Drobish, Amy A ^a   Anders, Carey K ^a   Carey, Lisa A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; BREAST CONSERVATION; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HUMAN; LOCALLY ADVANCED BREAST CANCER; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOME ASSESSMENT; SURVIVAL RATE; TREATMENT RESPONSE;

ADULT; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80052042228     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Beadle BM, Woodward WA, Tucker SL, et al. Ten- Year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys 2009;73: 734-44.
2. Veronesi U, Cascinelli N,Mariani L, et al. Twenty- Year follow- Year followUp of a randomized study comparing breast- Year followUp of a randomized study comparing breastConserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347: 1227-32. (Pubitemid 35176241)
3. Xiong Q, Valero V, Kau V, et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis: The M.D. Anderson Cancer Center experience. Cancer 2001;92:2523-8. (Pubitemid 33049434)
4. Anders CK, Fan C, Parker JS, et al. Breast carcinomas arising at a young age: Unique biology or a surrogate for aggressive intrinsic subtypes? J Clin Oncol 2011;29:e18-20.
5. Anders CK, Hsu DS, Broadwater G, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008;26:3324-30.
6. Wolmark N, Wang J, Mamounas E, et al. Preoperative chemotherapy in patients with operable breast cancer: nine- Year results from National Surgical Adjuvant Breast and Bowel Project B- Year results from National Surgical Adjuvant Breast and Bowel Project B Regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B18. J Natl Cancer Inst Monogr 2001;30:96-102.
7. Makris A, Powles TJ, Ashley SE, et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 1998;11:1179-84. (Pubitemid 28552806)
8. Cance WG, Carey LA, Calvo BF, et al. Long- Term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 2002;236: 295-302.
9. Chen AM, Meric-Bernstam F, Hunt KK, et al. Breast conservation after neoadjuvant chemotherapy: The M.D. Anderson Cancer Center experience. J Clin Oncol 2004;22:2303-12. (Pubitemid 41115386)
10. Fisher ER, Wang J, Bryant J, et al. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer 2002;95: 681-95. (Pubitemid 34845919)
11. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local- Regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997;15:2483-93. (Pubitemid 27289876)
12. Huang EH, Strom EA, Perkins GH, et al. Comparison of risk of local- Regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys 2006;66:352-7. (Pubitemid 44332738)
13. Hartley MC, McKinley BP, Rogers EA, et al. Differential expression of prognostic factors and effect on survival in young (< or 440) breast cancer patients: a case- Control study. Am Surg 2006;72:1189-94. (Pubitemid 351837902)
14. Kim SH, Simkovich-Heerdt A, Tran KN, et al. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J Am Coll Surg 1998;187: 1-8. (Pubitemid 28303528)
15. Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B- 18 and B- 18 and B27. J Clin Oncol 2008;26:778-85. (Pubitemid 351264391)